Health Results-Based Financing Impact Evaluation 2011, Health Facility Baseline Survey
Zambia, 2011
Get Microdata
Reference ID
ZMB_2011_HRBFIE-HFBL_v01_M
Producer(s)
Jed Friedman
Metadata
Created on
Oct 12, 2023
Last modified
Oct 12, 2023
Page views
43779
Downloads
351
PID (s8id)
Data file: utilhmis
Overview
Valid:
4884
Invalid:
0
Minimum:
1
Maximum:
40
Type:
Discrete
Decimal:
0
Width:
66
Range:
1 - 40
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | Contraceptive pill | 138 |
2.8%
|
| 2 | Injection | 138 |
2.8%
|
| 3 | Implant insertion | 136 |
2.8%
|
| 4 | Male condoms | 136 |
2.8%
|
| 5 | Intrauterine Device (IUD) insertion | 133 |
2.7%
|
| 6 | Female sterilization | 133 |
2.7%
|
| 7 | Male sterilization | 134 |
2.7%
|
| 8 | Prenatal care | 134 |
2.7%
|
| 9 | Spontaneous Vaginal Delivery | 137 |
2.8%
|
| 10 | Ceasarian section | 136 |
2.8%
|
| 11 | Assisted (forcepts, vaccuum) | 135 |
2.8%
|
| 12 | Home delivery with skilled staff | 126 |
2.6%
|
| 13 | Postnatal care | 135 |
2.8%
|
| 14 | Bacille Calmette Guerin (BCG) | 137 |
2.8%
|
| 15 | Pentavalent Dose 1 (DPT, Hepatitis B, Hemophilus influenzae B) | 136 |
2.8%
|
| 16 | Pentavalent Dose 2 (DPT, Hepatitis B, Hemophilus influenzae B) | 134 |
2.7%
|
| 17 | Pentavalent Dose 3 (DPT, Hepatitis B, Hemophilus influenzae B) | 133 |
2.7%
|
| 18 | Polio Dose 1 | 133 |
2.7%
|
| 19 | Polio Dose 2 | 131 |
2.7%
|
| 20 | Polio Dose 3 | 129 |
2.6%
|
| 21 | Measles Dose 1 (<1 year) | 129 |
2.6%
|
| 22 | Tetanus Toxoid to pregnant women | 129 |
2.6%
|
| 23 | Curative and preventive care | 133 |
2.7%
|
| 24 | Curative care for children <5 years | 132 |
2.7%
|
| 25 | Curative care for children >5 years and adults | 131 |
2.7%
|
| 26 | Child growth monitoring and nutritional advice | 128 |
2.6%
|
| 27 | Diagnosis for falciparum malaria | 126 |
2.6%
|
| 28 | Diagnosis for non-falciparum malaria | 129 |
2.6%
|
| 29 | Malaria treatment with Artemisinin-based Combination Therapy (ACT) | 128 |
2.6%
|
| 30 | Tuberculosis diagnosis | 128 |
2.6%
|
| 31 | Tuberculosis treatment | 12 |
0.2%
|
| 32 | Sexually Transmitted Infections services | 120 |
2.5%
|
| 33 | Diagnosis, treatment, testing, and counseling | 14 |
0.3%
|
| 34 | HIV/AIDS services | 128 |
2.6%
|
| 35 | Voluntary Counseling and Testing (VCT) | 130 |
2.7%
|
| 36 | Prevention of HIV/AIDS Mother-To-Child Transmission (PMTCT) | 127 |
2.6%
|
| 37 | Antiretrovial Treatment (ART) | 123 |
2.5%
|
| 38 | 24-hour emergency care | 125 |
2.6%
|
| 39 | Inpatient stay | 120 |
2.5%
|
| 40 | Ambulance ride to another facility for referral | 8 |
0.2%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.